SCHEMBL25460146

SCHEMBL25460146

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4c(-c5ccc6oc7c8ccccc8ccc7c6c5)cccc34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 9/20 0.41
CYP1B1 Q16678 9/20 0.41
CYP1A2 P05177 8/20 0.41
HPGD P15428 5/20 0.41
KDM4E B2RXH2 4/20 0.41
MAPT P10636 4/20 0.41
TSHR P16473 4/20 0.41
HSD17B10 Q99714 4/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPK1 P28482 3/20 0.41
PRKDC P78527 3/20 0.41
TP53 P04637 2/20 0.41
ABCG2 Q9UNQ0 2/20 0.41
PDE5A O76074 1/20 0.41
ABCB1 P08183 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP19A1 P11511 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2B6 P20813 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25668581 0.94 MAPT (0.42) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL25847150 0.93 ALOX5 (0.39) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL22879833 0.93 ALDH1A1 (0.43) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL19916934 0.90 ALDH1A1 (0.39) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL24215861 0.90 ALOX5 (0.45) HPGDKDM4EMAPTTSHRHSD17B10
SCHEMBL26243868 0.89 ALDH1A1 (0.42) CYP1A2HPGDKDM4EMAPTTSHR
SCHEMBL25460155 0.89 ALDH1A1 (0.38) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL25460315 0.89 CYP1A1 (0.44) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL19916927 0.89 CYP1A1 (0.44) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL24222244 0.89 CYP1A1 (0.46) CYP1A1CYP1B1CYP1A2HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230157168-A1 PLURALITY OF HOST MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-05-18 US disclosed
US-20230157168-A1 PLURALITY OF HOST MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-05-18 US disclosed
US-20230141435-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-05-11 US disclosed
US-20230141435-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-05-11 US disclosed
US-20230141672-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-05-11 US disclosed
US-20230141672-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230141672-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME NECTIN4, SOD1, ELAVL1 CYP1A1 4038/4885CYP1B1 4100/4885CYP1A2 3794/4885
US-20230157168-A1 PLURALITY OF HOST MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, EPCAM, NECTIN4 CYP1A1 3994/4885CYP1B1 4102/4885CYP1A2 3800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.